Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial
German Cancer Research Center · National Center for Tumor Diseases · +10 more institutions
Indexed incrossrefdatacitepubmed
Abstract
No abstract available for this paper.
Citation impact
1,122
total citations
- FWCI
- 49.10
- Percentile
- 100%
- References
- 32
Citations per year
Authors
18- WWWolfgang WickCorresponding
German Cancer Research Center, National Center for Tumor Diseases, Hertie Institute for Clinical Brain Research, Heidelberg University, University of Tübingen
- MPMichael Platten
Heidelberg University, National Center for Tumor Diseases, German Cancer Research Center, University of Tübingen, Hertie Institute for Clinical Brain Research
- CMChristoph Meisner
University of Tübingen
- JFJörg Felsberg
Heinrich Heine University Düsseldorf
- GTGhazaleh Tabatabai
Hertie Institute for Clinical Brain Research, University Hospital of Zurich, University of Tübingen
Topics & keywords
Topics
Keywords
- Temozolomide
- Medicine
- Radiation therapy
- Anaplastic astrocytoma
- Hazard ratio
- Clinical endpoint
- Chemotherapy
- Internal medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.